Careers  |  Sign In  |  Register

Latest in Women’s Health

An experimental women’s libido drug, flibanserin, developed by Sprout Pharmaceuticals, has been advised for rejection by the FDA advisory panel, according to Reuters. Flibanserin is a selective serotonin reuptake inhibitor (SSRI) and was initially tested as an antidepressant. After it was found to be an...
Rashmi Roy, MD, FACS, points out that thyroid cancer is being diagnosed in more women than ever before. This is mainly due to the increased scrutiny physicians practice in their physical exams and imaging of a patient's neck. Signs of a suspicious ultrasound include micro-calcifications and/or nodules on the...
Each week we present the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates in the fields of medicine and healthcare.